$24.41
▼ -1.2% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ...
CeriBell, Inc. Q2 2026 Earnings Call Summary
Overview
52-week range
$11
$25
94% of range
Avg surprise (last 3)
-4.0%
Avg reaction (last 2)
+3.1%
50% positive
Latest IV / EM
87%
EM ±14.1% · $25 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.51 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-0.52 | $-0.39 | -33.3% | -44.4% | -0.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.37 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $-0.38 | $-0.40 | +5.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.36 | $-0.43 | +16.3% | — | +6.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.85 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.61 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.56 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.32 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28M | $26M | — | $23M | $21M | $20M | — | $17M |
| Cost of revenue | $2M | $3M | — | $3M | $3M | $2M | — | $2M |
| Gross profit | $26M | $23M | — | $20M | $19M | $18M | — | $15M |
| Operating income | $-20M | $-21M | — | $-15M | $-15M | $-14M | — | $-10M |
| Net income | $-19M | $-20M | — | $-13M | $-14M | $-13M | — | $-10M |
| EPS (diluted) | $-0.51 | $-0.52 | — | $-0.37 | $-0.38 | $-0.36 | — | $-1.85 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $33M | $45M | $40M | $24M | $40M | $153M | $194M | $14M |
| Inventory | $7M | $7M | $7M | $6M | $6M | $7M | $7M | $7M |
| Total current assets | $158M | $169M | $187M | $192M | $200M | $205M | $217M | $35M |
| Total assets | $166M | $178M | $196M | $200M | $208M | $213M | $225M | $47M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $38M | $37M | $40M | $35M | $36M | $33M | $34M | $36M |
| Total equity | $128M | $141M | $155M | $164M | $172M | $181M | $191M | $-136M |